Skip to main content
Tami John, MD, Pediatric Hematology & Oncology, Palo Alto, CA, Lucile Packard Children's Hospital Stanford

TamiDeniseJohnMD

Pediatric Hematology & Oncology Palo Alto, CA

Clinical Associate Professor, Pediatric Stem Cell Transplant and Regenerative Medicine

Dr. John is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. John's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Stem Cell Transplant, 2016 - 2017
  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2013 - 2016
  • University of California Davis Health
    University of California Davis HealthResidency, Pediatrics, 2010 - 2013
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2025
  • TX State Medical License
    TX State Medical License 2016 - 2023
  • OR State Medical License
    OR State Medical License 2011 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Early Career Clinician Award Baylor, 2021

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era
    Tami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders
    Tami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without C...
    Tami John, ASH annual meeting, 12/1/2019
  • Join now to see all

Lectures

  • Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Black Teen with Sickle Cell Disease First Gene Therapy Patient at Texas Medical Center
    Black Teen with Sickle Cell Disease First Gene Therapy Patient at Texas Medical CenterMarch 17th, 2022
  • Katy Teen Is the First Texas Medical Center Patient to Receive Gene Therapy for Sickle Cell Disease
    Katy Teen Is the First Texas Medical Center Patient to Receive Gene Therapy for Sickle Cell DiseaseMarch 15th, 2022

Hospital Affiliations